The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lung Cancer-Global Market Insights and Sales Trends 2024
Synopsis
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
The global Lung Cancer market size is expected to reach US$ 33610 million by 2029, growing at a CAGR of 7.7% from 2023 to 2029. The market is mainly driven by the significant applications of Lung Cancer in various end use industries. The expanding demands from the Hospital & Clinics, Cancer Research Centers and Others,, are propelling Lung Cancer market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lung Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lung Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lung Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lung Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lung Cancer covered in this report include Roche, Novartis, Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly And Company and Sanof, etc.
The global Lung Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly And Company
Sanof
Global Lung Cancer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lung Cancer market, Segment by Type:
Surgery
Chemotherapy
Radiotherapy
Photodynamic Therapy
Laser Therapy
Global Lung Cancer market, by Application
Hospital & Clinics
Cancer Research Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lung Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
The global Lung Cancer market size is expected to reach US$ 33610 million by 2029, growing at a CAGR of 7.7% from 2023 to 2029. The market is mainly driven by the significant applications of Lung Cancer in various end use industries. The expanding demands from the Hospital & Clinics, Cancer Research Centers and Others,, are propelling Lung Cancer market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lung Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lung Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lung Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lung Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lung Cancer covered in this report include Roche, Novartis, Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly And Company and Sanof, etc.
The global Lung Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly And Company
Sanof
Global Lung Cancer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lung Cancer market, Segment by Type:
Surgery
Chemotherapy
Radiotherapy
Photodynamic Therapy
Laser Therapy
Global Lung Cancer market, by Application
Hospital & Clinics
Cancer Research Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lung Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Lung Cancer
1.1 Lung Cancer Market Overview
1.1.1 Lung Cancer Product Scope
1.1.2 Lung Cancer Market Status and Outlook
1.2 Global Lung Cancer Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Lung Cancer Market Size by Region (2018-2029)
1.4 Global Lung Cancer Historic Market Size by Region (2018-2023)
1.5 Global Lung Cancer Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Lung Cancer Market Size (2018-2029)
1.6.1 North America Lung Cancer Market Size (2018-2029)
1.6.2 Europe Lung Cancer Market Size (2018-2029)
1.6.3 Asia-Pacific Lung Cancer Market Size (2018-2029)
1.6.4 Latin America Lung Cancer Market Size (2018-2029)
1.6.5 Middle East & Africa Lung Cancer Market Size (2018-2029)
2 Lung Cancer Market by Type
2.1 Introduction
2.1.1 Surgery
2.1.2 Chemotherapy
2.1.3 Radiotherapy
2.1.4 Photodynamic Therapy
2.1.5 Laser Therapy
2.2 Global Lung Cancer Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Lung Cancer Historic Market Size by Type (2018-2023)
2.2.2 Global Lung Cancer Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Lung Cancer Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Lung Cancer Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Lung Cancer Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Lung Cancer Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Lung Cancer Revenue Breakdown by Type (2018-2029)
3 Lung Cancer Market Overview by Application
3.1 Introduction
3.1.1 Hospital & Clinics
3.1.2 Cancer Research Centers
3.1.3 Others
3.2 Global Lung Cancer Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Lung Cancer Historic Market Size by Application (2018-2023)
3.2.2 Global Lung Cancer Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Lung Cancer Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Lung Cancer Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Lung Cancer Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Lung Cancer Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Lung Cancer Revenue Breakdown by Application (2018-2029)
4 Lung Cancer Competition Analysis by Players
4.1 Global Lung Cancer Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer as of 2022)
4.3 Date of Key Players Enter into Lung Cancer Market
4.4 Global Top Players Lung Cancer Headquarters and Area Served
4.5 Key Players Lung Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 Lung Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Lung Cancer Products, Services and Solutions
5.1.4 Roche Lung Cancer Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Lung Cancer Products, Services and Solutions
5.2.4 Novartis Lung Cancer Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Lung Cancer Products, Services and Solutions
5.3.4 Pfizer Lung Cancer Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Lung Cancer Products, Services and Solutions
5.4.4 Merck Lung Cancer Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Profile
5.5.2 Bristol-Myers Squibb Main Business
5.5.3 Bristol-Myers Squibb Lung Cancer Products, Services and Solutions
5.5.4 Bristol-Myers Squibb Lung Cancer Revenue (US$ Million) & (2018-2023)
5.5.5 Bristol-Myers Squibb Recent Developments
5.6 Eli Lilly And Company
5.6.1 Eli Lilly And Company Profile
5.6.2 Eli Lilly And Company Main Business
5.6.3 Eli Lilly And Company Lung Cancer Products, Services and Solutions
5.6.4 Eli Lilly And Company Lung Cancer Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly And Company Recent Developments
5.7 Sanof
5.7.1 Sanof Profile
5.7.2 Sanof Main Business
5.7.3 Sanof Lung Cancer Products, Services and Solutions
5.7.4 Sanof Lung Cancer Revenue (US$ Million) & (2018-2023)
5.7.5 Sanof Recent Developments
6 North America
6.1 North America Lung Cancer Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Lung Cancer Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lung Cancer Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lung Cancer Market Dynamics
11.1 Lung Cancer Industry Trends
11.2 Lung Cancer Market Drivers
11.3 Lung Cancer Market Challenges
11.4 Lung Cancer Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
